Insider
Date
Role
Action
Shares
Price
Amount
Stephen P. Carey
29 Oct 2026
SVP & CFO
Sold on a plan
2,850
$72.87
$207.68K
Nikhil Lalwani
15 Oct 2026
President & CEO
Sold on a plan
5,400
$71.89
$388.21K
Meredith Cook
13 Oct 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$73.59
$36.80K
Stephen P. Carey
29 Sep 2026
SVP & CFO
Sold on a plan
2,850
$73.00
$208.05K
Nikhil Lalwani
15 Sep 2026
President & CEO
Sold on a plan
5,400
$71.00
$383.40K
Meredith Cook
14 Sep 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$70.79
$35.40K
Jeanne Thoma
11 Sep 2026
Director
Sold on a plan
1,000
$71.53
$71.53K
Stephen P. Carey
31 Aug 2026
SVP & CFO
Sold on a plan
2,850
$72.80
$207.48K
Nikhil Lalwani
25 Aug 2026
President & CEO
Sold on a plan
5,400
$74.30
$401.22K
Meredith Cook
13 Aug 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$75.48
$37.74K
Ori Gutwerg
10 Aug 2026
SVP, Generics
Sell
3,162
$77.00
$243.47K
Stephen P. Carey
29 Jul 2026
SVP & CFO
Sold on a plan
2,850
$81.36
$231.88K
Meredith Cook
13 Jul 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$81.84
$40.92K
Stephen P. Carey
2 Jul 2026
SVP & CFO
Sold after exercise
3,313
$86.00
$284.92K
Stephen P. Carey
29 Jun 2026
SVP & CFO
Sold on a plan
2,850
$84.12
$239.74K
Meredith Cook
12 Jun 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$82.03
$41.02K
Thomas Haughey
8 Jun 2026
Director
Sold on a plan
2,000
$80.88
$161.76K
Stephen P. Carey
5 Jun 2026
SVP & CFO
Sold after exercise
3,312
$80.00
$264.96K
Meredith Cook
13 May 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$78.16
$39.08K
Patrick D Walsh
13 May 2026
Director
Sell
10,000
$80.63
$806.30K
Ori Gutwerg
12 May 2026
SVP, Generics
Sell
2,772
$79.50
$220.37K
Thomas Andrew Rowland
12 May 2026
SVP, Head - Established Brands
Sell
459
$79.21
$36.36K
Nikhil Lalwani
11 May 2026
President & CEO
Sell
55,000
$77.57
$4.27M
Patrick D Walsh
11 May 2026
Director
Sell
3,973
$80.75
$320.82K
Meredith Cook
13 Apr 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$77.95
$38.98K
Meredith Cook
13 Mar 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$72.62
$36.31K
Christopher Mutz
13 Mar 2026
Head of Rare Disease
Sold on a plan
3,162
$71.64
$226.53K
Thomas Andrew Rowland
11 Mar 2026
SVP, Head - Established Brands
Sell
4,772
$74.91
$357.47K
Krista Davis
9 Mar 2026
SVP, Chief HR Officer
Sold on a plan
5,087
$74.13
$377.10K
Christopher Mutz
9 Mar 2026
Head of Rare Disease
Sold on a plan
3,602
$74.18
$267.20K
Krista Davis
6 Mar 2026
SVP, Chief HR Officer
Sold on a plan
1,485
$75.00
$111.38K
Christopher Mutz
6 Mar 2026
Head of Rare Disease
Sold on a plan
2,121
$74.22
$157.42K
Stephen P. Carey
5 Mar 2026
SVP & CFO
Sold after exercise
4,000
$75.56
$302.24K
Stephen P. Carey
5 Mar 2026
SVP & CFO
Sold after exercise
3,312
$75.42
$249.79K
Patrick D Walsh
3 Mar 2026
Director
Sell
6,000
$74.23
$445.38K
Ori Gutwerg
3 Mar 2026
SVP, Generics
Sell
2,060
$76.50
$157.59K
Christopher Mutz
2 Mar 2026
Head of Rare Disease
Sold on a plan
417
$74.00
$30.86K
Krista Davis
20 Feb 2026
SVP, Chief HR Officer
Sold on a plan
1,730
$77.99
$134.92K
Christopher Mutz
20 Feb 2026
Head of Rare Disease
Sold on a plan
5,323
$78.02
$415.30K
Krista Davis
19 Feb 2026
SVP, Chief HR Officer
Sold on a plan
2,084
$77.53
$161.57K
Meredith Cook
13 Feb 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$76.80
$38.40K
Christopher Mutz
12 Feb 2026
Head of Rare Disease
Sold on a plan
7,032
$76.55
$538.30K
Meredith Cook
13 Jan 2026
Sr. VP, General Counsel & Sec.
Sold on a plan
500
$84.33
$42.17K
Krista Davis
18 Dec 2025
SVP, Chief HR Officer
Sold on a plan
1,622
$82.40
$133.65K
Meredith Cook
12 Dec 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$82.32
$32.93K
Renee P Tannenbaum
5 Dec 2025
Director
Sell
1,800
$81.15
$146.07K
Meredith Cook
13 Nov 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$87.27
$34.91K
Chad Gassert
13 Nov 2025
SVP - Corp. Dev. & Strategy
Sell
indirect
94
$88.00
$8.27K
Patrick D Walsh
13 Nov 2025
Director
Sell
8,643
$86.88
$750.90K
Chad Gassert
12 Nov 2025
SVP - Corp. Dev. & Strategy
Sell
indirect
14,642
$89.07
$1.30M
Meredith Cook
13 Oct 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$90.09
$36.04K
Krista Davis
19 Sep 2025
SVP, Chief HR Officer
Sold on a plan
1,000
$98.04
$98.04K
Meredith Cook
12 Sep 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$98.42
$39.37K
Antonio R Pera
3 Sep 2025
Director
Sell
7,292
$94.94
$692.30K
Matthew J Leonard
25 Aug 2025
Director
Sell
2,528
$90.62
$229.09K
Krista Davis
22 Aug 2025
SVP, Chief HR Officer
Sell
1,763
$91.10
$160.61K
Muthusamy Shanmugam
21 Aug 2025
Head of R&D, COO-Novitium Ops
Sell
indirect
52,988
$90.44
$4.79M
Antonio R Pera
20 Aug 2025
Director
Sell
5,421
$89.73
$486.43K
Muthusamy Shanmugam
20 Aug 2025
Head of R&D, COO-Novitium Ops
Sell
indirect
47,012
$90.27
$4.24M
Matthew J Leonard
18 Aug 2025
Director
Sell
6,937
$88.17
$611.64K
Jeanne Thoma
18 Aug 2025
Director
Sell
14,675
$88.87
$1.30M
Jeanne Thoma
18 Aug 2025
Director
Sell
6,865
$89.76
$616.20K
Chad Gassert
15 Aug 2025
SVP - Corp. Dev. & Strategy
Sell
indirect
20,000
$86.97
$1.74M
Muthusamy Shanmugam
15 Aug 2025
Head of R&D, COO-Novitium Ops
Sell
indirect
52,990
$87.15
$4.62M
Patrick D Walsh
15 Aug 2025
Director
Sell
9,000
$89.05
$801.45K
Muthusamy Shanmugam
14 Aug 2025
Head of R&D, COO-Novitium Ops
Sell
indirect
47,010
$89.48
$4.21M
Meredith Cook
13 Aug 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$88.87
$35.55K
Thomas Haughey
12 Aug 2025
Director
Sell
19,341
$85.93
$1.66M
Stephen P. Carey
12 Aug 2025
SVP & CFO
Sold after exercise
50,000
$86.07
$4.30M
Ori Gutwerg
12 Aug 2025
SVP, Generics
Sell
5,873
$86.53
$508.19K
Nikhil Lalwani
12 Aug 2025
President & CEO
Sell
56,960
$85.93
$4.89M
Thomas Andrew Rowland
12 Aug 2025
SVP, Head - Established Brands
Sell
4,975
$85.71
$426.41K
Meredith Cook
14 Jul 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$64.88
$25.95K
Meredith Cook
13 Jun 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$61.37
$24.55K
Ori Gutwerg
15 May 2025
SVP, Generics
Sell
881
$60.07
$52.92K
Christopher Mutz
14 May 2025
Head of Rare Disease
Sell
4,000
$60.45
$241.80K
Meredith Cook
13 May 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$62.20
$24.88K
Muthusamy Shanmugam
9 May 2025
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
700
$76.83
$53.78K
Meredith Cook
14 Apr 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$68.96
$27.58K
Krista Davis
19 Mar 2025
SVP, Chief HR Officer
Sold on a plan
1,866
$65.00
$121.29K
Meredith Cook
13 Mar 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$63.33
$25.33K
Krista Davis
7 Mar 2025
SVP, Chief HR Officer
Sold on a plan
1,000
$60.86
$60.86K
Ori Gutwerg
5 Mar 2025
SVP, Generics
Sold after exercise
5,084
$60.00
$305.04K
Ori Gutwerg
5 Mar 2025
SVP, Generics
Sold after exercise
300
$60.03
$18.01K
Krista Davis
21 Feb 2025
SVP, Chief HR Officer
Sold on a plan
1,000
$60.20
$60.20K
Meredith Cook
13 Feb 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$59.54
$23.82K
Meredith Cook
13 Jan 2025
Sr. VP, General Counsel & Sec.
Sold on a plan
400
$53.92
$21.57K
Stephen P. Carey
17 Dec 2024
SVP & CFO
Sell
7,500
$55.79
$418.43K
Meredith Cook
13 Dec 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$56.24
$14.06K
Krista Davis
11 Dec 2024
SVP, Chief HR Officer
Sold on a plan
1,000
$60.00
$60.00K
Nikhil Lalwani
26 Nov 2024
President & CEO
Sold after exercise
3,481
$58.30
$202.94K
Nikhil Lalwani
26 Nov 2024
President & CEO
Sold after exercise
30,000
$57.95
$1.74M
Christopher Mutz
15 Nov 2024
Head of Rare Disease
Sell
6,500
$57.70
$375.05K
Meredith Cook
13 Nov 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$61.36
$15.34K
Meredith Cook
14 Oct 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$57.19
$14.30K
Meredith Cook
13 Sep 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$56.82
$14.21K
Meredith Cook
13 Aug 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$59.62
$14.91K
Muthusamy Shanmugam
18 Jul 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
2,743
$62.00
$170.07K
Muthusamy Shanmugam
17 Jul 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
14,257
$63.16
$900.47K
Muthusamy Shanmugam
16 Jul 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
22,000
$64.27
$1.41M
Muthusamy Shanmugam
15 Jul 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
11,000
$63.38
$697.18K
Meredith Cook
12 Jul 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$64.91
$16.23K
Chad Gassert
1 Jul 2024
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$63.44
$1.27M
Muthusamy Shanmugam
21 Jun 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
20,000
$58.90
$1.18M
Muthusamy Shanmugam
20 Jun 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
11,447
$59.86
$685.22K
Muthusamy Shanmugam
18 Jun 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
10,607
$60.76
$644.48K
Muthusamy Shanmugam
17 Jun 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
7,946
$61.41
$487.96K
Meredith Cook
13 Jun 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$63.80
$15.95K
James G. Marken
7 Jun 2024
SVP Ops & Prod Dev
Exercised, kept
5,300
$57.06
$302.42K
James G. Marken
7 Jun 2024
SVP Ops & Prod Dev
Exercised, kept
7,250
$49.51
$358.95K
Ori Gutwerg
5 Jun 2024
SVP, Generics
Sell
2,985
$67.00
$200.00K
Stephen P. Carey
4 Jun 2024
SVP & CFO
Sell
5,000
$63.58
$317.90K
Chad Gassert
3 Jun 2024
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$64.41
$1.29M
Christopher Mutz
21 May 2024
Head of Rare Disease
Sell
2,000
$61.61
$123.22K
Muthusamy Shanmugam
20 May 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
12,855
$61.81
$794.57K
Muthusamy Shanmugam
17 May 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
5,836
$62.09
$362.36K
Renee P Tannenbaum
16 May 2024
Director
Sell
2,000
$63.87
$127.74K
Muthusamy Shanmugam
16 May 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
16,459
$63.84
$1.05M
Muthusamy Shanmugam
15 May 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
14,850
$65.86
$978.02K
Nikhil Lalwani
14 May 2024
President & CEO
Sell
16,669
$66.10
$1.10M
Meredith Cook
13 May 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$67.69
$16.92K
Chad Gassert
1 May 2024
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$66.62
$1.33M
Muthusamy Shanmugam
19 Apr 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
16,809
$65.17
$1.10M
Muthusamy Shanmugam
18 Apr 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
10,423
$64.98
$677.29K
Muthusamy Shanmugam
17 Apr 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
9,520
$65.40
$622.61K
Muthusamy Shanmugam
16 Apr 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
5,834
$66.20
$386.21K
Muthusamy Shanmugam
15 Apr 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
7,414
$66.33
$491.77K
Meredith Cook
12 Apr 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$67.79
$16.95K
Chad Gassert
1 Apr 2024
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$67.25
$1.35M
Meredith Cook
13 Mar 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$66.54
$16.64K
Stephen P. Carey
11 Mar 2024
SVP & CFO
Sell
7,787
$65.55
$510.44K
Chad Gassert
11 Mar 2024
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$65.81
$1.32M
Nikhil Lalwani
8 Mar 2024
President & CEO
Sell
16,292
$67.13
$1.09M
Muthusamy Shanmugam
8 Mar 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
10,000
$67.17
$671.70K
Muthusamy Shanmugam
7 Mar 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
15,085
$66.35
$1.00M
James G. Marken
7 Mar 2024
SVP Ops & Prod Dev
Sell
24,338
$66.37
$1.62M
Muthusamy Shanmugam
6 Mar 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
14,822
$65.47
$970.40K
Nikhil Lalwani
6 Mar 2024
President & CEO
Sell
28,965
$65.52
$1.90M
Christopher Mutz
5 Mar 2024
Head of Rare Disease
Sell
5,000
$66.00
$330.00K
Muthusamy Shanmugam
5 Mar 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
10,093
$65.35
$659.58K
Antonio R Pera
4 Mar 2024
Director
Sell
7,000
$65.20
$456.40K
Meredith Cook
13 Feb 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$56.04
$14.01K
Muthusamy Shanmugam
23 Jan 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
15,000
$56.44
$846.60K
Muthusamy Shanmugam
22 Jan 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
5,692
$55.95
$318.47K
Muthusamy Shanmugam
19 Jan 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
4,524
$55.57
$251.40K
Muthusamy Shanmugam
18 Jan 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
9,784
$55.30
$541.06K
Muthusamy Shanmugam
17 Jan 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
10,000
$55.11
$551.10K
Muthusamy Shanmugam
16 Jan 2024
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
5,000
$55.63
$278.15K
Meredith Cook
12 Jan 2024
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$56.43
$14.11K
Muthusamy Shanmugam
19 Dec 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
25,000
$52.65
$1.32M
Muthusamy Shanmugam
18 Dec 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
13,026
$52.44
$683.08K
Muthusamy Shanmugam
15 Dec 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
11,974
$52.44
$627.92K
Meredith Cook
11 Dec 2023
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$49.21
$12.30K
Muthusamy Shanmugam
17 Nov 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
13,000
$51.00
$663.00K
Muthusamy Shanmugam
16 Nov 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
6,448
$51.66
$333.10K
Muthusamy Shanmugam
15 Nov 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
7,647
$53.64
$410.19K
Krista Davis
15 Nov 2023
SVP, Chief HR Officer
Sell
2,622
$53.81
$141.09K
Muthusamy Shanmugam
14 Nov 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
22,095
$53.17
$1.17M
Meredith Cook
13 Nov 2023
Sr. VP, General Counsel & Sec.
Sold on a plan
250
$52.03
$13.01K
Christopher Mutz
10 Nov 2023
Head of Rare Disease
Sell
3,000
$52.47
$157.41K
Muthusamy Shanmugam
19 Oct 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
10,000
$57.06
$570.60K
Muthusamy Shanmugam
18 Oct 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
6,242
$57.78
$360.66K
Muthusamy Shanmugam
17 Oct 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
8,758
$58.53
$512.61K
Muthusamy Shanmugam
16 Oct 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
13,063
$58.31
$761.70K
Muthusamy Shanmugam
13 Oct 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
11,937
$57.58
$687.33K
Chad Gassert
2 Oct 2023
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$56.48
$1.13M
Muthusamy Shanmugam
19 Sep 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
25,333
$61.23
$1.55M
Muthusamy Shanmugam
18 Sep 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
8,425
$61.64
$519.32K
Muthusamy Shanmugam
15 Sep 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
16,242
$62.81
$1.02M
Chad Gassert
1 Sep 2023
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$64.70
$1.29M
Muthusamy Shanmugam
29 Aug 2023
Head of R&D, COO-Novitium Ops
Sell
indirect
25,000
$63.37
$1.58M
Muthusamy Shanmugam
28 Aug 2023
Head of R&D, COO-Novitium Ops
Sell
indirect
25,000
$63.06
$1.58M
James G. Marken
23 Aug 2023
SVP Ops & Prod Dev
Sold after exercise
3,932
$63.00
$247.72K
Ori Gutwerg
23 Aug 2023
SVP, Generics
Sold after exercise
2,059
$62.39
$128.46K
Ori Gutwerg
23 Aug 2023
SVP, Generics
Sold after exercise
13,502
$62.39
$842.39K
Meridian Venture Partners II LP
16 Aug 2023
10% owner
Sell
200,000
$58.50
$11.70M
Nikhil Lalwani
15 Aug 2023
President & CEO
Sold after exercise
11,616
$61.13
$710.09K
Muthusamy Shanmugam
15 Aug 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
22,110
$61.60
$1.36M
Antonio R Pera
14 Aug 2023
Director
Sold on a plan
3,000
$60.37
$181.11K
Stephen P. Carey
14 Aug 2023
SVP & CFO
Sell
17,639
$61.37
$1.08M
Muthusamy Shanmugam
14 Aug 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
27,890
$61.15
$1.71M
Nikhil Lalwani
11 Aug 2023
President & CEO
Sell
56,666
$57.75
$3.27M
Chad Gassert
1 Aug 2023
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$51.06
$1.02M
Muthusamy Shanmugam
21 Jul 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
11,500
$52.56
$604.44K
Muthusamy Shanmugam
20 Jul 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
6,000
$51.52
$309.12K
Muthusamy Shanmugam
19 Jul 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
5,969
$51.48
$307.28K
Muthusamy Shanmugam
18 Jul 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
6,700
$51.84
$347.33K
Muthusamy Shanmugam
17 Jul 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
9,831
$51.06
$501.97K
Muthusamy Shanmugam
14 Jul 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
indirect
10,000
$50.43
$504.30K
Chad Gassert
3 Jul 2023
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$53.43
$1.07M
Muthusamy Shanmugam
22 Jun 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
13,500
$51.38
$693.63K
Chad Gassert
22 Jun 2023
SVP - Corp. Dev. & Strategy
Sold on a plan
indirect
20,000
$51.32
$1.03M
Muthusamy Shanmugam
21 Jun 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
11,843
$51.95
$615.24K
Muthusamy Shanmugam
20 Jun 2023
Head of R&D, COO-Novitium Ops
Sold on a plan
14,657
$51.93
$761.14K
Meridian Venture Partners II LP
1 Dec 2022
10% owner
Sell
200,000
$38.50
$7.70M
James G. Marken
15 Aug 2022
SVP Ops & Prod Dev
Sell
5,172
$37.79
$195.46K
James G. Marken
12 Aug 2022
SVP Ops & Prod Dev
Sell
12,894
$37.04
$477.61K
Chad Gassert
21 Mar 2022
SVP - Corp. Dev. & Strategy
Buy
indirect
5,000
$27.87
$139.34K
Patrick D Walsh
21 Mar 2022
Director
Buy
5,000
$27.76
$138.79K
Nikhil Lalwani
21 Mar 2022
President & CEO
Buy
7,224
$27.69
$200.00K
Chad Gassert
18 Mar 2022
SVP - Corp. Dev. & Strategy
Buy
indirect
5,000
$27.15
$135.74K
Muthusamy Shanmugam
17 Mar 2022
Head of R&D, COO-Novitium Ops
Buy
indirect
5,000
$27.65
$138.25K
Muthusamy Shanmugam
17 Mar 2022
Head of R&D, COO-Novitium Ops
Buy
5,000
$27.65
$138.25K
Jeanne Thoma
20 Dec 2021
Director
Buy
1,072
$46.47
$49.82K
Antonio R Pera
7 Dec 2021
Director
Buy
3,000
$42.26
$126.79K
Thomas Haughey
6 Dec 2021
Director
Buy
2,500
$39.38
$98.45K
Patrick D Walsh
15 Mar 2021
Director
Buy
4,000
$32.89
$131.56K
Patrick D Walsh
9 Nov 2020
Director
Buy
5,000
$25.96
$129.80K
Patrick D Walsh
10 Aug 2020
Chairman, Interim Pres. & CEO
Buy
3,000
$30.89
$92.67K
Patrick D Walsh
10 Aug 2020
Chairman, Interim Pres. & CEO
Buy
4,000
$30.98
$123.92K
Patrick D Walsh
10 Aug 2020
Chairman, Interim Pres. & CEO
Buy
3,000
$30.40
$91.20K
Thomas Haughey
4 Mar 2020
Director
Buy
3,000
$45.05
$135.15K
Thomas Haughey
3 Mar 2020
Director
Buy
2,000
$45.18
$90.36K
Meridian Venture Partners II LP
20 Aug 2019
10% owner
Sell
5,512
$68.18
$375.81K
Meridian Venture Partners II LP
19 Aug 2019
10% owner
Sell
2,067
$68.30
$141.18K
Meridian Venture Partners II LP
16 Aug 2019
10% owner
Sell
26,349
$68.09
$1.79M
Meridian Venture Partners II LP
15 Aug 2019
10% owner
Sell
9,315
$69.34
$645.90K
Meridian Venture Partners II LP
14 Aug 2019
10% owner
Sell
26,360
$69.89
$1.84M
Meridian Venture Partners II LP
13 Aug 2019
10% owner
Sell
20,821
$71.77
$1.49M
Meridian Venture Partners II LP
12 Aug 2019
10% owner
Sell
21,016
$71.45
$1.50M
Meridian Venture Partners II LP
9 Aug 2019
10% owner
Sell
19,860
$71.70
$1.42M
David Nash
24 May 2019
Director
Buy
1,445
$68.76
$99.36K
James G. Marken
17 May 2019
SVP Ops & Prod Dev
Sell
8,907
$70.67
$629.46K
Robert E. Brown JR
16 May 2019
Director
Exercised, kept
1,167
$33.00
$38.51K
Robert E. Brown JR
16 May 2019
Director
Exercised, kept
1,042
$6.36
$6.63K
Thomas Haughey
15 May 2019
Director
Buy
2,500
$69.30
$173.24K
Arthur Przybyl
15 May 2019
President and CEO
Sell
14,633
$69.25
$1.01M
James G. Marken
14 May 2019
SVP Ops & Prod Dev
Sell
4,917
$70.31
$345.71K
Arthur Przybyl
14 May 2019
President and CEO
Sell
5,772
$70.45
$406.64K
Robert W Schrepfer
13 May 2019
SVP - New Bus Dev & Spec Sales
Sell
2,409
$71.13
$171.35K
Arthur Przybyl
13 May 2019
President and CEO
Sell
9,595
$71.10
$682.20K
Arthur Przybyl
19 Mar 2019
President and CEO
Sold after exercise
2,823
$63.51
$179.29K
Arthur Przybyl
18 Mar 2019
President and CEO
Sold after exercise
24,802
$63.53
$1.58M
Robert W Schrepfer
13 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
4,651
$64.43
$299.65K
Robert W Schrepfer
12 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
1,503
$64.50
$96.94K
Robert W Schrepfer
12 Mar 2019
SVP - New Bus Dev & Spec Sales
Sold after exercise
5,642
$64.44
$363.58K
Robert W Schrepfer
11 Sep 2018
SVP - New Bus Dev & Spec Sales
Exercised, kept
28,688
$6.60
$189.34K
Tracy Marshbanks
16 May 2018
Director
Sell
indirect
25,706
$62.40
$1.60M
Tracy Marshbanks
15 May 2018
Director
Sell
indirect
7,024
$62.05
$435.84K
Tracy Marshbanks
14 May 2018
Director
Sell
indirect
5,506
$62.35
$343.30K
Tracy Marshbanks
10 May 2018
Director
Sell
indirect
24,229
$62.03
$1.50M
Tracy Marshbanks
10 May 2018
Director
Sell
indirect
17,685
$62.14
$1.10M
Tracy Marshbanks
9 May 2018
Director
Sell
indirect
20,517
$62.05
$1.27M
Tracy Marshbanks
18 Apr 2018
Director
Sell
indirect
33,200
$62.09
$2.06M
Daniel Raynor
19 Mar 2018
Director
Sell
indirect
5,313
$60.62
$322.07K
Daniel Raynor
15 Mar 2018
Director
Sell
indirect
1,902
$61.50
$116.97K
Daniel Raynor
14 Mar 2018
Director
Sell
indirect
1,919
$62.02
$119.02K
Arthur Przybyl
14 Mar 2018
President and CEO
Sell
10,000
$62.03
$620.30K
Tracy Marshbanks
14 Mar 2018
Director
Sell
indirect
1,912
$63.10
$120.65K
Daniel Raynor
13 Mar 2018
Director
Sell
indirect
4,117
$62.59
$257.68K
